Browse Articles
Discover research articles across all indexed journals
Unraveling the role of NLRP1-mediated inflammation in glioblastoma pathophysiology.
74 Background: Glioblastoma (GBM) is the most aggressive type of brain cancer with a median survival of less than 14 months even after surgery, chemo, and radiotherapy. Innate and adaptive immune cells express members of the nucleotide-binding domain, leucine-rich repeat-containing receptors (NLRs), a family of pattern recognition receptors. NLRs are central to innate immunity, detect danger signals, and form a multi-protein cytosolic complex called the inflammasome that plays a critical role in regulating innate immunity and cancer development. NLRP1 is the first discovered inflammasome sensor that contains a pyrin domain, leucine-rich repeats (LRRs), and a caspase recruitment domain (CARD). The CARD domain recruits Caspase-1 that can cleave pro-inflammatory cytokines IL-1β and IL-18, which may regulate cell death. NLRP1 inflammasome activation positively correlates with breast cancer. The exact role of NLRP1 in glioblastoma remains undiscovered. This research aims to assess the role of NLRP1 in glioblastoma pathophysiology. Methods: RNA-seq data from TCGA-LGG (low-grade glioma) (n=523), TCGA-GBM (n=166), and GTEx normal brain tissues (n=1141) were taken from the UCSC Xena platform. Differential expression across tumor grades was analyzed using R packages (v4.4.1). Overall survival (OS) was assessed using Kaplan–Meier analysis with log-rank testing. Immune cell infiltration correlations were evaluated using TIMER 2.0 with the CIBERSORT algorithm. DNA methylation data from TCGA were analyzed to assess correlations between promoter-associated CpG β-values and NLRP1 expression. NLRP1 protein expression was evaluated using immunohistochemistry and immunocytochemistry on normal and GBM tissue and cell lines, respectively. Results: NLRP1 expression was significantly elevated in lower-grade glioma (LGG) relative to GBM and normal brain tissue. Low-grade glioma patients with high NLRP1 expression demonstrate significantly poorer overall survival (p=0.027). NLRP1-associated immune cell infiltration is higher in lower-grade glioma than in GBM. Promoter-proximal CpG sites showed moderate-to-strong negative correlations with expression. ICC shows NLRP1 is differentially expressed in astrocytes (SVG) and GBM (LN229) cell lines. NLRP1 is differentially expressed in the astrocytes and microglia of GBM and the non-tumor-associated brain tissues. Conclusions: NLRP1 integrates with the remodeling of the GBM microenvironment and is associated with adverse survival in LGG. These findings position NLRP1 as a potential prognostic biomarker and immunometabolic therapeutic target.
Fine-Tuning the Coordination Structure and Identifying Pt <sub>1</sub> –O <sub>v</sub> –Ce as the Active Site for Selective Hydrogenations over Pt <sub>1</sub> /CeO <sub>2</sub> Single-Atom Catalysts
Correction: Effect of microencapsulated sodium butyrate on abdominal symptoms and carbohydrate metabolism in patients with type 2 diabetes: a randomized placebo-controlled trial
Droplet Electricity Generators With Maximized Energy Collection Zone Enabled by Aloe‐Inspired Midrib and Cuticle (Adv. Mater. 39/2026)
Inverse Design of Amorphous Materials With Targeted Properties
ABSTRACT Disordered (amorphous) materials, such as glasses, are emerging as promising candidates for applications within energy storage, nonlinear optics, and catalysis. Their lack of long‐range order and complex short‐ and medium‐range order, which depend on composition as well as thermal and pressure history, offer a vast materials design space. To this end, relying on machine learning methods instead of trial and error is promising, and among these, inverse design has emerged as a tool for generating materials with desired properties. Although inverse design methods based on diffusion models have shown success for crystalline materials and molecules, similar methods targeting amorphous materials remain less developed, mainly because of the limited availability of large‐scale datasets and the requirement for larger simulation cells. In this work, we propose and validate an inverse design method for amorphous materials, introducing AMDEN (Amorphous Material DEnoising Network), a diffusion model‐based framework that generates structures of amorphous materials. First, we demonstrate the inherent challenges for diffusion models to generate relaxed structures. These low‐energy configurations are typically obtained through a thermal motion‐driven random search‐like process that cannot be replicated by standard denoising procedures. We therefore introduce an energy‐based AMDEN variant that implements Hamiltonian Monte Carlo refinement for generating these relaxed structures. We further introduce several amorphous material datasets with diverse properties and compositions to evaluate our framework and support future development.
Macrophage-specific targeting of histone demethylases with small-molecule inhibitors suppresses inflammatory response in vivo
Fibroblast growth factor receptor 3 (FGFR3) alterations and response to immune checkpoint inhibition in metastatic urothelial carcinoma: A systematic review and meta-analysis.
182 Background: Immune checkpoint inhibitors (ICIs) have become a cornerstone in the treatment of metastatic urothelial carcinoma (mUC). Fibroblast growth factor receptor 3 (FGFR3) alterations, present in up to 20% of mUC patients, have been proposed as a potential biomarker influencing response to ICIs, supported by preclinical evidence suggesting that FGFR3-driven tumors exhibit a T-cell-depleted tumor microenvironment, potentially limiting ICIs efficacy. This systematic review and meta-analysis aimed to evaluate the association between FGFR3 alterations and treatment response and survival outcomes in patients with mUC treated with ICIs. Methods: A systematic literature search was conducted from database inception to 10 November 2025 to identify studies reporting outcomes of immune checkpoint inhibitor therapy in metastatic urothelial carcinoma stratified by FGFR3 alteration status. Databases searched included PubMed/MEDLINE, Embase, CENTRAL, Web of Science, Scopus and Cochrane Central Register of Controlled Trials. Eligible studies comprised prospective or retrospective cohort studies, phase I–III clinical trials, and registry-based analyses of adult patients with mUC receiving ICIs, with outcomes reported by FGFR3 status, with outcomes stratified by FGFR3 status. Key outcomes were objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS) and overall survival (OS). Pooled effect estimates were calculated using random-effects models, with subgroup analyses were performed according to treatment line. Results: Fifteen studies involving 2,179 eligible patients with mUC treated with ICIs were included. ORRs were comparable between FGFR3-altered and wild-type tumours (RR 0.82 95% CI 0.63-1.07). In contrast, FGFR3-altered tumors demonstrated a significantly lower DCR compared with FGFR3 wild-type tumors (RR 0.75, 95% CI 0.57-0.96), particularly in second-line or later treatment settings (RR 0.58, 95% CI 0.41–0.82). FGFR3 alterations were significantly associated with inferior OS (HR 1.25, 95% CI 1.08–1.44) and PFS (HR 1.63, 95% CI 1.23–2.16). The association with poorer OS was stronger in second-line or later treatment settings (HR 1.70, 95% CI 1.18-2.44). Conclusions: FGFR3 alterations in mUC are associated with inferior disease control and poorer survival outcomes in patients treated with ICIs. These findings support FGFR3 alterations as a negative prognostic marker in the immunotherapy setting and highlight the potential role of therapeutic strategies combining FGFR inhibition with immunotherapy to optimize outcomes in FGFR-altered mUC.
Phototheranostic Sutures Integrated with NIR-II Emissive Photosensitizers for Postoperative Complication Prevention and Non-invasive Monitoring
Outside Front Cover: Toward Multi(radio)Metalated DNA: Enzymatic Polymerization of Metal‐Chelate‐Modified Deoxyribonucleoside Triphosphates (Angew. Chem. Int. Ed. 27/2026)
A fuzzy multi-criteria decision-making framework for the comparative analysis of human and AI influencers
Correction to “Surface‐Engineered Orthopedic Implant to Break the Antimicrobial‐Osteogenic Paradox at Biointerfaces in the ‘Race for the Surface”
Approaching Zero Voltage Attenuation of Lithium‐Rich Cathodes through Electrochemical Relaxation
ABSTRACT Li‐rich cathodes combining cationic/anionic redox have rejuvenated high‐energy batteries. However, their practical applications remain constrained by the inferior anion redox reversibility and stability. Herein, a facile electrochemical relaxation route was implemented for the first time in the initial charging process to tune the anion redox chemistry. It declares the electrochemical relaxation in the oxygen activation plateau of 4.6 V contributes to a lattice framework with reduced structural distortion and weakened O─O interactions. A back‐bonding π ‐bond is formed between Mn and the O─O dimer, strengthening the interactions between oxygen and Mn, mitigating structural degradation and local distortion during the electrochemical cycling. The relaxed material demonstrates a high capacity over 250 mAh g −1 and a high plateau voltage of 3.57 V with a negligible voltage decay (0.8%) after 100 cycles at 1C. This strategy presents a straightforward methodology for high‐voltage activation of O redox cathodes.
Control of the committed step in lipopolysaccharide biosynthesis
SPP1⁺ macrophage influence on differentiation of radioiodine-refractory thyroid cancer through secretion of FABP4.
239 Background: Radioiodine-refractory papillary thyroid carcinoma (RR-PTC) is a dedifferentiated subtype of thyroid cancer characterized by reduced iodine uptake and insensitivity to radioactive iodine (^131I) therapy. However, the mechanisms underlying tumor dedifferentiation and radioiodine refractoriness remain incompletely understood. Methods: Based on our previous single-cell RNA sequencing analyses of RR-PTC samples, we characterized the immune microenvironment and tumor cell states associated with dedifferentiation. Functional studies were conducted using a murine papillary thyroid cancer cell line (MPTC) derived from a BRAFV600E-mutant mouse model. The effects of targeting SPP1⁺ macrophages and macrophage-derived FABP4 on tumor growth were evaluated. Mechanistic investigations focused on FABP4-associated metabolic pathways, and clinical specimens were analyzed to assess the relationship between SPP1/FABP4 expression, tumor differentiation status, and patient prognosis. Results: Single-cell transcriptomic analysis revealed a marked increase in myeloid cell infiltration, particularly SPP1⁺ macrophages, in RR-PTC tumors, accompanied by pronounced tumor cell dedifferentiation. In the BRAFV600E-driven MPTC model, antagonizing SPP1⁺ macrophages or their secreted protein FABP4 effectively suppressed tumor growth. Further mechanistic studies demonstrated that FABP4 forms a hormone-like complex, termed Fabkin, with adenosine kinase (ADK) and nucleoside diphosphate kinase (NDPK). This complex induces metabolic reprogramming in thyroid cancer cells, thereby promoting dedifferentiation and progressive loss of iodine uptake capacity. Analysis of clinical samples showed that SPP1 and FABP4 expression levels increased in parallel with tumor dedifferentiation and were significantly associated with poor prognosis. Conclusions: This study proposes that SPP1⁺ macrophages and macrophage-derived FABP4 play a critical role in shaping the immune microenvironment and driving metabolic reprogramming–mediated dedifferentiation in RR-PTC. Elucidating this mechanism may provide novel therapeutic strategies to prevent or reverse the progression of differentiated thyroid cancer toward radioiodine-refractory disease.
Photoswitchable Molecular Spur Gears: An Entry Point to Motorized Gearing
Nanoscale Spatial Engineering of Ligands Using DNA Origami for Precise Modulation of Membrane Receptor Signaling
ABSTRACT Dimerization or multimerization of surface membrane receptors is essential for transmitting extracellular recognition events across the plasma membrane, triggering intracellular signaling cascades, and regulating a wide range of cellular functions. Ligands typically act as inducers for these processes by binding to receptors, promoting their aggregation and subsequent dimerization or multimerization. The precise spatial arrangement of ligands is crucial for minimizing random collisions and non‐directed migration of receptors on the cell membrane, thereby enhancing signaling fidelity. DNA origami, a highly versatile self‐assembly technique, has emerged as a powerful tool for generating a wide variety of DNA nanostructures. Its exceptional programmability and spatial addressability enable fine‐tuned control over ligand spatial arrangement at the nanoscale, facilitating the precise modulation of surface membrane receptor signaling and enabling user‐defined biological investigations. In this review, we explore the methods used to engineer the spatial arrangement of ligands through DNA origami, highlighting its unique advantages in controlling ligand distance, valence, spatial configuration, and stoichiometry. We also present current applications of DNA origami for modulating membrane receptor signaling, while addressing the key challenges and future directions in achieving precise nanoscale spatial arrangements of ligands for biological and therapeutic purposes.
A Topological Fingerprint Encodes Motor Skill at Rest
In this study, we investigated whether the architecture of brain interactions at rest maintains a representation of individual behavioral skills. Specifically, we aimed to identify a minimal set of topological features that capture an electrophysiological mechanism underlying the encoding of a motor skill. We tested whether brain network topology at rest could model individual performance in a motor task, such as manual dexterity, in 86 subjects of either sex from the Human Connectome Project. Using a machine learning procedure, we identified an optimal fingerprint that accurately modeled individual manual dexterity, encompassing four participation index-based connector hubs in the alpha frequency band, involving the parietal cortex. A vulnerability analysis, in which we simulated disconnections of the involved hubs, revealed that two of them were critical, resulting in a significant drop in predictive performance. We combined these features to propose a functional “refocusing” mechanism: hubs progressively prune connections external to their modules when dexterity increases, while maintaining an internal representation of dexterity performance. Such inhibition and maintenance are well aligned with the role of the alpha band reported in the literature. These findings suggest that the architecture of interactions at rest, by combining few topological features in the alpha band, encodes stable behavioral traits, such as motor skills.
Efficacy of aminolevulinic acid photodynamic therapy plus CO₂ laser for cervical intraepithelial neoplasia grade 2: a retrospective study
AI–Guided 4D Printing of Carnivorous Plants–Inspired Microneedles for Accelerated Wound Healing (Adv. Mater. 39/2026)
Breaking the Adsorption Seesaw Via Asymmetric Pt‐M Sites for PET Electro‐Upcycling
ABSTRACT Electrochemical upgrading of polyethylene terephthalate (PET) waste to high‐value glycolic acid (GA) offers a sustainable route for plastic valorization. However, due to the uniform and limited electron density, the adsorption of the key intermediate ethylene glycol (EG) and hydroxyl (OH) on Pt catalysts is restricted by a linear‐scaling‐governed “see‐saw” relationship, which inevitably leads to a fundamental activity bottleneck. Herein, we find that constructing asymmetric nucleophilic – electrophilic Pt – M sites can overcome this bottleneck via coupled electronic and geometric effects. The nucleophilic Pt sites favor the moderate adsorption of EG, while the electrophilic M sites favor OH adsorption, breaking the linear‐scaling constraint. The synthesized Pt – Fe nanowires with asymmetric dual sites display breakthrough intrinsic activity with an onset potential of 0.225 V vs. RHE for GA evolution, and achieve energy – effective GA production in a continuous flow electrolyzer with a daily revenue of $258.97/ton in PET upcycling. Operando characterization confirms that the asymmetric construction disrupts the linear adsorption coupling behavior. Importantly, an “asymmetric dual – site electronic – geometric coupling” descriptor is proposed to capture the decoupled adsorption behavior, which is applicable to other Pt – M (Fe, Co, Ni, Pd, Au) catalysts.